Updated:
Ouro Partners
Ouro Partners is a US-based family office established in 2007. It specializes in connecting institutional investors with fund managers in the biotech and...
Overview
Ouro Partners is a US-based family office established in 2007. It specializes in connecting institutional investors with fund managers in the biotech and life science sectors.
General information
Firm type
Bank / Wealth / Trust
Location
Region
North America
Country
United States
City
New York
Corporate office
New York, NY, United States
Sector focus
Frequently asked questions
What is Ouro Partners' investment strategy?
Ouro Partners is a dedicated secondaries firm. It acquires existing limited partner interests in private equity, venture capital, growth equity, and real assets funds from investors seeking early liquidity. The firm does not make primary fund commitments or direct co-investments — its entire mandate revolves around the secondary market, where it operates as a buyer of seasoned fund stakes through LP-led and GP-led transactions.
Who runs investment decisions at Ouro Partners?
The firm has not disclosed its leadership team or investment committee structure in public filings or through a corporate website. No named principals, portfolio managers, or deal leads are verifiable through standard financial databases, regulatory records, or industry publications as of the most recent review period.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: